![]() |
![]() |
Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
Bank Loan Ratings | 6.00 | ACUITE B | Reaffirmed & Withdrawn | Issuer not co-operating* | - |
Bank Loan Ratings | 3.70 | Not Applicable | Withdrawn | - |
Bank Loan Ratings | 2.30 | - | ACUITE A4 | Reaffirmed & Withdrawn | Issuer not co-operating* |
Total Outstanding | 0.00 | - | - |
Total Withdrawn | 12.00 | - | - |
* The issuer did not co-operate; based on best available information. |
Rating Rationale |
Acuité has reaffirmed and withdrawn the long-term rating of 'ACUITE B' (read as ACUITE B) on the Rs. 6.00 crore bank facilities of Sri Sai Appa Biocare (SSAB). Acuité has also reaffirmed and withdrawn the short term rating of ‘ACUITE A4’ (read as ACUITE A four) on the Rs. 2.30 crore bank facilities of Sri Sai Appa Biocare (SSAB). The rating is being withdrawn on account of request received from the company and No Objection Certificate received from the banker.
Acuité has also withdrawn its long term proposed facility on the Rs. 3.70 crore bank facilities of Sri Sai Appa Biocare (SSAB) without assigning any rating as the limit is proposed instrument. The rating is being withdrawn on account of request received from the company. The rating withdrawal is in accordance with Acuité's policy on withdrawal of rating as applicable to the respective facility / instrument. The rating continues to be flagged as “Issuer Not-Cooperating” and is based on the best available information. |
About the Company |
Sri Sai Appa Biocare (SSAB) is a Chennai based partnership firm established in 2016. The firm is promoted by Mr. Ramesh Kulandaraj, Mr. Siva, Mr. Kailasanathan J and Mr. S Soundararajan. SSAB distributes medical devices of various principals across Southern India and its major presence is in Tamil Nadu and Pondicherry. Some of the key principals of SSAB include renowned global companies in the medical devices industry such as Medtronic Inc., Abbott Vascular (AV) Inc., and St. Jude Medical, Inc. and Teleflex.
|
Unsupported Rating |
Not Applicable
|
Non-cooperation by the issuer/borrower: |
Acuité has been requesting for data, information and undertakings from the rated entity for conducting surveillance & review of the rating. However, the issuer/borrower failed to submit such information before the due date. Acuité believes that information risk is a critical component in such ratings, and non-cooperation by the issuer along with unwillingness to provide information could be a sign of potential deterioration in its overall credit quality. This rating is, therefore, being flagged as “Issuer not-cooperating”, in line with prevailing SEBI regulations and Acuité’s policies.
|
Limitation regarding information availability |
Rating Sensitivity |
"No information provided by the issuer / available for Acuite to comment upon." |
Liquidity Position |
"No information provided by the issuer / available for Acuite to comment upon." |
Outlook: Not Applicable |
|
Other Factors affecting Rating |
None |
Particulars | Unit | FY 20 (Provisional) | FY 19 (Actual) |
Operating Income | Rs. Cr. | 17.68 | 14.07 |
PAT | Rs. Cr. | 0.13 | 0.08 |
PAT Margin | (%) | 0.72 | 0.57 |
Total Debt/Tangible Net Worth | Times | 1.30 | 1.89 |
PBDIT/Interest | Times | 1.20 | 1.17 |
Status of non-cooperation with previous CRA |
Not Applicable |
Any other information |
None |
Applicable Criteria |
• Trading Entities: https://www.acuite.in/view-rating-criteria-61.htm • Default Recognition: https://www.acuite.in/view-rating-criteria-52.htm • Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm |
Note on complexity levels of the rated instrument |
|
|
|
||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||
* The issuer did not co-operate; based on best available information. |
Contacts |
About Acuité Ratings & Research |
© Acuité Ratings & Research Limited. All Rights Reserved. | www.acuite.in |